Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · IEX Real-Time Price · USD
2.860
-0.040 (-1.38%)
Jul 2, 2024, 4:30 PM EDT - Market closed
Aytu BioPharma Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$5.00
Upside
+74.83%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +74.83% | Aug 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +599.30% | May 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $220 → $120 | Strong Buy | Maintains | $220 → $120 | +4,095.80% | Jul 21, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $220 → $100 | Buy | Maintains | $220 → $100 | +3,396.50% | May 17, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $480 → $220 | Strong Buy | Maintains | $480 → $220 | +7,592.31% | Apr 28, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 30, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | May 29, 2020 |
| Northland Capital Markets | Northland Capital Markets | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 22, 2018 |